logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Moss, David
    Born in March 1970
    Individual (1 offspring)
    Officer
    icon of calendar 2016-04-06 ~ now
    OF - Director → CIF 0
  • 2
    Lowdell, Mark William
    Born in March 1962
    Individual (5 offsprings)
    Officer
    icon of calendar 2016-04-06 ~ now
    OF - Director → CIF 0
Ceased 1
  • Tesi, Raymond Joseph
    Director born in October 1955
    Individual
    Officer
    icon of calendar 2016-04-06 ~ 2025-08-13
    OF - Director → CIF 0
parent relation
Company in focus

INMUNE BIO INTERNATIONAL LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
601,913 GBP2024-12-31
366,217 GBP2023-12-31
Debtors
791,444 GBP2024-12-31
850,774 GBP2023-12-31
Cash at bank and in hand
43,171 GBP2024-12-31
83,599 GBP2023-12-31
Current Assets
834,615 GBP2024-12-31
934,373 GBP2023-12-31
Net Current Assets/Liabilities
-20,672,812 GBP2024-12-31
-17,281,378 GBP2023-12-31
Total Assets Less Current Liabilities
-20,070,899 GBP2024-12-31
-16,915,161 GBP2023-12-31
Equity
Called up share capital
10 GBP2024-12-31
10 GBP2023-12-31
Retained earnings (accumulated losses)
-20,070,909 GBP2024-12-31
-16,915,171 GBP2023-12-31
Equity
-20,070,899 GBP2024-12-31
-16,915,161 GBP2023-12-31
Average Number of Employees
72024-01-01 ~ 2024-12-31
62023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Other
719,193 GBP2024-12-31
435,260 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
117,280 GBP2024-12-31
69,043 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
48,237 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Other
601,913 GBP2024-12-31
366,217 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
287,578 GBP2024-12-31
287,578 GBP2023-12-31
Amounts Owed By Related Parties
433,313 GBP2024-12-31
Current
433,313 GBP2023-12-31
Other Debtors
Amounts falling due within one year
70,553 GBP2024-12-31
129,883 GBP2023-12-31
Debtors
Amounts falling due within one year, Current
791,444 GBP2024-12-31
Current, Amounts falling due within one year
850,774 GBP2023-12-31
Trade Creditors/Trade Payables
Current
366,345 GBP2024-12-31
158,462 GBP2023-12-31
Amounts owed to group undertakings
Current
21,101,788 GBP2024-12-31
18,047,875 GBP2023-12-31
Other Creditors
Current
39,294 GBP2024-12-31
9,414 GBP2023-12-31
Creditors
Current
21,507,427 GBP2024-12-31
18,215,751 GBP2023-12-31

  • INMUNE BIO INTERNATIONAL LIMITED
    Info
    Registered number 10105962
    icon of addressC/o Keystone Law )attn:simon Holden), 48 Chancery Lane, London WC2A 1JF
    PRIVATE LIMITED COMPANY incorporated on 2016-04-06 (9 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-05
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.